WeVote
Log In

Bill

Bill

AJR 37

Relating to: declaring May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month.

2025-2026 Regular Session Introduced by Dave Armstrong and 5 co-sponsors

AJR 37 designates May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month to educate the public and support affected individuals.

Failed to concur in pursuant to Senate Joint Resolution 1
0
WeVote Research Nonpartisan
Bill Summary · AJR 37

Summary of AJR 37: Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month

Purpose and Intent

AJR 37 is a joint resolution that aims to declare May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month. The resolution seeks to raise awareness about these conditions, which affect connective tissues in the body, leading to a range of health issues. By designating a specific month for awareness, the bill intends to educate the public, promote understanding, and support individuals affected by these disorders.

Key Provisions

  • Designation of Awareness Month: The resolution officially recognizes May 2025 as a month dedicated to raising awareness about Ehlers-Danlos Syndromes (EDS) and Hypermobility Spectrum Disorders (HSD).
  • Promotion of Education and Advocacy: The resolution encourages educational initiatives and advocacy efforts to inform the public and healthcare professionals about the symptoms, challenges, and management of EDS and HSD.

Affected Parties

  • Individuals with EDS and HSD: The primary beneficiaries of this resolution are individuals diagnosed with Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders, as well as their families and caregivers.
  • Healthcare Providers: The resolution aims to enhance the understanding of these conditions among healthcare professionals, potentially leading to better diagnosis and treatment options.
  • General Public: Increased awareness may foster a more supportive environment for those affected by these disorders.

Legislative Timeline and Actions

  • Introduced: May 02, 2025, by Representatives Armstrong, Dittrich, Brown, Madison, O'Connor, and Sinicki, with co-sponsorship from Senators James, Keyeski, Ratcliff, and Spreitzer.
  • Committee Review: The resolution was read and referred to the Committee on Rules on the same day it was introduced.
  • Adoption and Messaging: The resolution was adopted on May 13, 2025, and was ordered to be messaged immediately.
  • Further Actions: On May 14, 2025, the resolution was read and referred to the committee on Senate Organization, where it is currently available for scheduling.

Conclusion

AJR 37 serves as an important step towards increasing awareness and understanding of Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders. By designating May 2025 for this purpose, the resolution aims to foster education, support advocacy efforts, and ultimately improve the quality of life for those affected by these conditions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.